Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

Annual conventional Pap smear is cost effective to reduce cancer incidence and mortality

A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy.

21 Oct 2010

CDC: Hispanics more likely to have HIV than whites, but live longer

The Associated Press: Officials from the Centers for Disease Control and Prevention "estimate that 1 in 22 black Americans will be diagnosed with the AIDS virus in their lifetime — more than twice the risk for Hispanics and eight times that of whites. ... the lifetime risk is 1 in 52 for Hispanics, and 1 in 170 for whites. Asian-Americans had the lowest lifetime risk, at about 1 in 222" (10/14).

15 Oct 2010

First Edition: October 15, 2010

Today's top stories from major news organizations report on the effort by 20 states to challenge the federal health law, a new federal panel to inform consumers about health care options and the struggle to pay for cancer care.

15 Oct 2010

Israeli's have higher life expectancy than Americans and other OECD members

A new study conducted by a researcher at Ben-Gurion University of the Negev (BGU) for Jerusalem's Taub Center for Social Policy Studies in Israel reports that Israeli's have a higher life expectancy on average than Americans and residents of other OECD (Organization for Economic Cooperation and Development) countries.

14 Oct 2010

U.S. Bone and Joint Decade observes National Action Week

An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.

14 Oct 2010

Patients with advanced cancer undergo common non-beneficial cancer screening tests

A sizeable proportion of patients with advanced cancer and a life expectancy of only a few years continue to undergo common cancer screening tests that are unlikely to provide meaningful benefit, according to a study in the October 13 issue of JAMA.

13 Oct 2010

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).

13 Oct 2010

US continues to lag behind other nations when it comes to gains in life expectancy: Study

America continues to lag behind other nations when it comes to gains in life expectancy, and commonly cited causes for our poor performance-obesity, smoking, traffic fatalities and homicide-are not to blame, according to a study by researchers at Columbia University's Mailman School of Public Health.

8 Oct 2010

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Aimed at enhancing the capacity of Mozambique's flagship medical school, Universidade Eduardo Modlane (UEM), in pre- and postgraduate medical education, the University of California, San Diego School of Medicine and UEM entered into a partnership in 2007 to address both short and long-term medical human resource needs in Mozambique.

7 Oct 2010

U.S. continues to lag behind other nations in life expectancy

The United States continues to lag behind other nations when it comes to gains in life expectancy, and commonly cited causes for our poor performance-obesity, smoking, traffic fatalities, and homicide-are not to blame, according to a Commonwealth Fund-supported study published today as a Health Affairs Web First.

7 Oct 2010

Researchers investigate ways to increase survival rate in patients with Parkinson's disease

New research shows how old people are when they first develop Parkinson's disease is one of many clues in how long they'll survive with the disease. The research is published in the October 5, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.

29 Sep 2010

Florida likely to seek waiver on medical loss ratio; Ariz. cuts back Medicaid benefits

The Hill Healthwatch: "Florida's 14-member insurance advisory board has unanimously passed a resolution to seek a waiver from the health law's medical loss ratio. An official with the Florida Office of Insurance Regulation tells The Hill that the board's vote means it's a 'done deal' that the state will formally seek some kind of waiver but the board is gathering public input through Oct. 8.

29 Sep 2010

Wealthy live longer than the poor: Study

According to the latest research poorer Australians die at least three years before their wealthy counterparts. The report entitled, “The Health Lies in Wealth” by the University of Canberra's National Centre for Social and Economic Modeling found that people in the lowest socio-economic group died on average at 79.6 years of age compared with 82.7 years for the highest socio-economic group. Factors that influence life expectancy include household income, work status, education level and support networks.

26 Sep 2010

Phase II study: Fostamatinib improves outcomes in RA patients

AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.

23 Sep 2010

ACT people live longer but may have more mental health issues: Report

Chief Health Officer Charles Guest's report on the health and wellbeing of the Australian Capital Territory (ACT) population between July 2006 and June 2008 was presented in the Legislative Assembly. It showed that life expectancy rate at birth in the ACT was 80.3 years for males and 84 for women. This was despite the fact that most are overweight and only a minority eats enough fruit and vegetables.

22 Sep 2010

Tips to protect physical health

Fifteen years ago, the non-profit Educational Television Network created Healthy Aging Month to focus attention on the positive aspects of getting older and to encourage people to learn how to increase longevity and avoid preventable declines in physical, mental and emotional health. Healthy aging is of particular interest as life expectancy in the United States continues to rise. According to the Centers for Disease Control and Prevention, in 2007 the life expectancy was 75.4 for men and 80.4 for women .

21 Sep 2010

VIVUS announces QNEXA study results for obesity treatment

VIVUS, Inc. today announced positive top-line results from a two-year study of QNEXA(phentermine/topiramate) Controlled Release Capsules, an investigational therapy for treatment of obesity, a condition that affects approximately one-third of adult Americans.

21 Sep 2010

Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).

21 Sep 2010

ALS Society of Canada applauds Prime Minister's commitment to ensure benefits for veterans with ALS

The ALS Society of Canada applauds Prime Minister Stephen Harper's September 17 announcement on Global National Television regarding veterans with ALS: "I think I've been pretty clear that supporting our veterans is one of the government's highest priorities. We've been doing some internal reviews. We're aware of some concerns on how veterans who have ALS may be handled and I've certainly been insisting our officials look into how we can fix some people's problems. So you're going to see some action on that in the not-too-distant future."

21 Sep 2010

Life Expectancy News and Research

Further Reading

Annual conventional Pap smear is cost effective to reduce cancer incidence and mortality

CDC: Hispanics more likely to have HIV than whites, but live longer

First Edition: October 15, 2010

Israeli's have higher life expectancy than Americans and other OECD members

U.S. Bone and Joint Decade observes National Action Week

Patients with advanced cancer undergo common non-beneficial cancer screening tests

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

US continues to lag behind other nations when it comes to gains in life expectancy: Study

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

U.S. continues to lag behind other nations in life expectancy

Researchers investigate ways to increase survival rate in patients with Parkinson's disease

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

Florida likely to seek waiver on medical loss ratio; Ariz. cuts back Medicaid benefits

Wealthy live longer than the poor: Study

Phase II study: Fostamatinib improves outcomes in RA patients

ACT people live longer but may have more mental health issues: Report

Tips to protect physical health

VIVUS announces QNEXA study results for obesity treatment

Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV

ALS Society of Canada applauds Prime Minister's commitment to ensure benefits for veterans with ALS

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News